Related Experiment Video

Updated: Jul 5, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Pediatric neurodegenerative white matter processes: leukodystrophies and beyond

Jonathan A Phelan1, Lisa H Lowe, Charles M Glasier

  • 1Department of Radiology, Kansas City University of Medicine and Biosciences, University of Missouri-Kansas City, and The Children's Mercy Hospital and Clinics, 1750 Independence Ave., Kansas City, MO 64106, USA. jphelan@kcumb.edu

Pediatric Radiology
|May 1, 2008
PubMed

Insights

This review guides radiologists in differentiating pediatric neurodegenerative white matter disorders. It focuses on distinguishing congenital metabolic leukodystrophies from other white matter conditions using neuroimaging.

Area of Science:

  • Neurology
  • Radiology
  • Pediatrics

Background:

  • Pediatric neurodegenerative white matter processes are diverse, stemming from causes like injury, inflammation, or metabolic disorders.
  • Accurate diagnosis is crucial for appropriate management and treatment of these complex conditions.

Purpose of the Study:

  • To provide a systematic approach for radiologists evaluating neurodegenerative white matter disorders in children.
  • To differentiate congenital metabolic leukodystrophies from other white matter pathologies.

Main Methods:

  • Review of neuroimaging findings in pediatric white matter diseases.
  • Discussion of differential diagnoses for white matter abnormalities.
  • Classification strategies for leukodystrophies.

Main Results:

  • Outlines a general diagnostic pathway for neurodegenerative white matter disorders.
  • Highlights key imaging features to distinguish metabolic leukodystrophies from mimics.
  • Presents an approach to classifying various white matter leukodystrophies.

Conclusions:

  • A structured approach aids in the accurate diagnosis of pediatric white matter disorders.
  • Distinguishing metabolic leukodystrophies from other white matter processes is a critical first step in neuroimaging interpretation.

More Related Videos

Mouse Models of Periventricular Leukomalacia06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse15:26

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse

Published on: May 19, 2015

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...